Chemplast Sanmar Ltd

- The exact capex for the upcoming R32 project is yet to be finalized, including its sizing. - Currently, only enabling approval for the project capex has been taken; actual capex will be decided once the sizing is finalized. - No specific details are provided regarding the funding mix between internal accruals and debt for the R32 project as of the call. - The only ongoing project mentioned with approved capex is the multipurpose block Phase 3 of Custom Manufacturing, progressing as per plan. - There is no explicit mention of new fundraising through debt or equity in the transcript. - Future capital deployment preference is indicated towards the Custom Manufactured Chemicals Division, with investments being triggered based on 60% visibility of orders. - Overall, any capital expenditure is to be carefully aligned with quota approvals and project sizing decisions before committing funds.

- The multipurpose block Phase 3 of Custom Manufacturing is ongoing and progressing as per approved capex limits with completion expected by Q3 FY '26. - Civil works for the next production block, MPB 4, have also commenced with a similar timeline. - The R32 refrigerant gas project has received environmental clearance; however, the exact sizing and total capex are yet to be decided. Current approvals are enabling in nature. - Final decisions on R32 project sizing and siting will be taken soon, keeping in mind quota approvals to ensure capital deployment aligns with entitlements. - Future capital deployment preference strongly favors the Custom Manufacturing and Custom Synthesis & Manufacturing Development (CSMD) business, with investments triggered upon achieving ~60% visibility in existing blocks.

- Specialty business capacity built during tough quarters is expected to act as a springboard for future growth. - Custom Manufactured Chemicals Division (CMCD) shows a strong and healthy pipeline with active customer engagement, expected to accelerate from next year. - Agro-chemical sector is recovering, with an increase in inquiries and expected ramp-up of sales volumes in CMCD. - Demand for Paste PVC in India is expected to grow at 7-8% annually. - Suspension PVC demand outlook remains positive with 4% growth in domestic demand this quarter. - Government infrastructure projects are expected to drive pipe demand, supporting PVC sales growth. - Renewable power initiatives may lead to cost savings, indirectly benefiting profitability and margins. - Expansion projects like MPB Phase 3 and the upcoming R32 project are progressing, underpinning future volume increases. Overall, Chemplast Sanmar is optimistic about steady growth driven by capacity expansion, recovering end markets, and improving trade remedy actions.

- Specialty business capacity built during the tough PVC market phase is expected to act as a springboard for future growth. - Custom Manufactured Chemicals Division (CMCD) shows strong pipeline; growth expected with new project phases (MPB 3 Phase 3 and MPB 4) completing by FY27. - Ag-chem sector recovery anticipated to accelerate inquiries and orders starting next year, supporting volume growth. - Renewable power projects covering 35-40% of power needs could save INR 50-60 crores, improving margins. - Anti-dumping duties (ADD) on Suspension and Paste PVC expected to improve spreads and reduce pricing pressure. - Market rationalization in China and possible PVC plant closures in Europe may stabilize global supply, benefiting margins. - Company targets medium to long-term growth primarily through CMCD investments beyond FY27. - Overall, management remains optimistic about margin improvement and volume growth driven by product mix and regulatory actions.

- The Custom Manufactured Chemicals Division (CMCD) dispatches are currently on track and as per schedule. - The multipurpose block Phase 3 expansion is progressing well, with completion expected in the next 2 to 3 months. - Construction for MPB 4 civil works is also nearing completion within the same timeline. - The pipeline of inquiries and customer engagement remains healthy and strong. - The company maintains very active engagement with customers, including multiple visits, audits, and inquiries over the past year. - Future investments and expansions in CMCD will be triggered once visibility for 60% of the current block is secured. - The focus remains on broadening the customer base, especially with global agro-chem majors diversifying supply chains. - Overall, the orderbook and pending orders are robust and support ongoing and future capacity expansions.